Morgan Stanley Maintains Underweight on Synchrony Finl, Raises Price Target to $31
Morgan Stanley analyst Betsy Graseck maintains Synchrony Finl (NYSE:SYF) with a Underweight and raises the price target from $29 to $31.
Credit Suisse Maintains Outperform on Synchrony Finl, Lowers Price Target to $37
Credit Suisse analyst Moshe Orenbuch maintains Synchrony Finl (NYSE:SYF) with a Outperform and lowers the price target from $38 to $37.
BMO Capital Maintains Outperform on Synchrony Finl, Lowers Price Target to $53
BMO Capital analyst James Fotheringham maintains Synchrony Finl (NYSE:SYF) with a Outperform and lowers the price target from $56 to $53.
US Stocks Mostly Higher; Synchrony Financial Earnings Top Views
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 90 points on Monday.
Earnings Scheduled For January 23, 2023
Companies Reporting Before The Bell
• Baker Hughes (NASDAQ:BKR) is expected to report quarterly earnings at $0.40 per share on revenue of $6.06 billion.
Baker Hughes, Synchrony Financial And 3 Stocks To Watch Heading Into Monday
With US stock futures trading slightly lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Fear & Greed Index Moves To ‘Greed’ Zone As Nasdaq Record Gains For Third Straight Week
The CNN Money Fear and Greed index moved to the "Greed" zone after US stocks closed higher on Friday.
The Dow Jones and S&P 500 recorded gains on Friday, snapping a three-session losing streak. The Nasdaq recorded sharp gains for the week, adding 0.55% gain to record its third positive week in a row.
10 Financials Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023
Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…
5 Value Stocks To Watch In The Financial Services Sector
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of…